Clinical trials
Radiotracer clinical trials
Below are recruiting radiotracer clinical trials, each written for real people, not researchers. We’re tracking 33 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06591429Recruiting
A study on hidden inflammation in multiple sclerosis
This study uses brain scans to look for hidden inflammation in people with multiple sclerosis who have not yet started a strong treatment. It aims to understand how this inflammation affects the disease and to help guide future therapies.
St Louis, MissouriAges 18 years+ - NCT06252493Recruiting
PET/MR scan for Crohn's disease scar tissue
This study is testing a new imaging method that uses a special PET/MR scan to see how active Crohn's disease is in your bowel. The scan uses a harmless radioactive tracer that attaches to scar tissue, which may help doctors better understand the disease and guide treatment.
Charlestown, MassachusettsAges 18–99 - NCT07774650RecruitingEarly Phase 1
Imaging study of immune activity in healthy volunteers
This study tests a new imaging agent that may help show immune activity in the body using a PET scan. It is being tested in healthy volunteers to see how it behaves and to help plan future studies.
New Haven, ConnecticutAges 18–60 - NCT07400263Recruiting
Testing a new imaging agent for epithelial tumors
This trial evaluates a new radioactive tracer that targets a protein called EpCAM found on many solid tumors. It aims to improve PET/CT scans for diagnosing and staging cancer. Participants will receive the tracer before their scheduled biopsy or surgery.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07284589RecruitingPhase 2
Ultralow dose pet scan for certain tumors
This trial tests a new way to take PET scan pictures using a very low amount of a radioactive tracer that targets a protein called SSTR2. It is designed to see if these scans can work well while reducing radiation exposure for patients with certain types of tumors.
Englewood, New JerseyAges 18–120 - NCT07217028RecruitingPhase 1
Safety study of a new PET tracer for head and neck cancer
This study tests a new radioactive tracer called [18F]NOTA-ABY030 to see if it's safe for people with head and neck cancer that may have spread. The tracer lights up cancer cells on a PET scan, helping doctors find tumors more clearly.
Nashville, TennesseeAges 18 years+ - NCT07152431Recruiting
Using a special scan to find scar tissue in Crohn's disease
This study uses a special imaging tracer (FAPI) to find scar tissue in the small intestine of people with Crohn's disease. The goal is to see if this scan can help doctors better understand which parts of the intestine are scarred, which may guide treatment decisions.
EdinburghAges 18–90 - NCT07140315RecruitingPhase 1
DK222 study for lung and bladder cancer
This trial tests a new imaging drug, DK222, to see how well it works in people with non-small cell lung cancer or bladder cancer who are about to start immunotherapy. It may help doctors see if the treatment is reaching the right targets.
Baltimore, MarylandAges 18 years+ - NCT07000851Recruiting
Brain Imaging Study in Corticobasal Syndrome
This study uses MRI scans to look at the brain in people with Corticobasal Syndrome (CBS). It aims to better understand the condition and may help find better ways to diagnose or treat it.
Rochester, MinnesotaAges 18 years+ - NCT06835426Recruiting
Imaging removed tissue during cancer surgery
This study tests a high-resolution PET-CT scanner that takes pictures of tissue removed during surgery to help doctors see if all the cancer has been removed. You might qualify if you are having surgery for a range of cancers including breast, prostate, thyroid, skin, gastrointestinal, or brain tumors.
Ghent, Oost VlaanderenAges 18 years+ - NCT07617688RecruitingEarly Phase 1
PET imaging tracer safety study in healthy volunteers
This early-stage study tests a new PET imaging agent (a radioactive tracer used in medical imaging) to understand how it moves through the body and the radiation dose it delivers. Researchers need healthy volunteers to help establish whether this imaging tool is safe for future patient use.
New Haven, ConnecticutAges 18–60 - NCT07488819Recruiting
Brain imaging study for people with PTSD or alcohol use disorder
This study uses a special brain scan (PET) to look at a protein called PDE4B in people with PTSD or alcohol use disorder. It may help researchers understand these conditions better.
New Haven, ConnecticutAges 18–70 - NCT05231798RecruitingPhase 2
PET and brain scans in adults with Down syndrome
This study looks at how well a brain chemical system works in adults with Down syndrome as they age, including how it relates to Alzheimer’s-type brain changes and thinking skills. It uses brain scans and memory/thinking tests to see whether these measures can help track risk or changes over time.
Nashville, TennesseeAges 18–55 - NCT06159335RecruitingPhase 3
PET/MR scan for brain metastasis imaging
This trial uses a special PET/MR scan with a radioactive tracer to help tell the difference between tumor regrowth and changes from radiation treatment in people with brain metastases. It may help doctors make better treatment decisions.
Madison, WisconsinAges 18 years+ - NCT06377553Enrolling by invitation
PET/MRI scan for endometriosis diagnosis
This study uses a combined PET/MRI scan to better see endometriosis in people who are already scheduled for laparoscopic surgery. It may help find spots of endometriosis that are hard to see with other tests.
Charlestown, MassachusettsAges 18–70 - NCT06280742Recruiting
Brain inflammation in multiple sclerosis: a PET-MRI imaging study
This study uses a special PET-MRI scan to look at brain inflammation in people with relapsing-remitting multiple sclerosis (RRMS). It may help researchers understand how inflammation changes when starting a stronger MS treatment.
LyonAges 18 years+ - NCT06265272Recruiting
PSMA-11 PET/MRI for Liver Cirrhosis
This study uses a special PET/MRI scan with a tracer called PSMA-11 to look at how liver cirrhosis affects the liver. It may help doctors better understand and monitor the disease.
Charlestown, MassachusettsAges 18–99 - NCT06171659Recruiting
PET/MRI scan to find pain sources after joint surgery
This study uses a special type of scan called PET/MRI to look for areas in the body that may be causing ongoing pain after joint replacement or arthroscopy. It aims to better understand why some people have pain that lasts months after surgery.
Madison, WisconsinAges 18–85 - NCT05942716RecruitingPhase 2
Testing how serotonin changes impulsivity in Tourette
This Phase 2 study looks at whether changing serotonin activity can affect impulsivity and related brain function in people with Tourette disorder. You may be asked to continue aripiprazole and complete brain scans that test how your brain responds during tasks.
BronAges 18–65 - NCT05808153Recruiting
Brain scans and thinking tests to track Huntington’s progression
This study uses special brain imaging and memory/thinking tests to find early “markers” that can predict how Huntington’s disease will progress over time. You may qualify as someone with early-stage Huntington’s or as a healthy control, if you meet specific safety and scoring requirements.
Créteil, Île-de-France RegionAges 18–65 - NCT05805839Enrolling by invitationPhase 2
Study uses brain scans to understand demyelinating diseases
This trial compares scan results in people with multiple sclerosis or related demyelinating conditions versus people without inflammatory demyelinating diseases. The goal is to better understand what’s happening in the brain and how sex differences may play a role.
Rochester, MinnesotaAges 18 years+ - NCT05630963Recruiting
Study sleep-like brain signaling in major depression
This trial looks at how a specific brain receptor related to pain signals (nociceptin/orphanin FQ receptor) may be involved in depression. It may help researchers understand depression better by comparing people with current versus past (remitted) major depression.
Belmont, MassachusettsAges 18–45 - NCT05582876Recruiting
PET/MR scan to plan personalized prostate cancer treatment
This study uses a special scan called PET/MR with a prostate-focused tracer to help doctors choose the best next treatment for prostate cancer. It may be most helpful if you are planning major treatment or if your cancer has come back after prior treatment.
BialystokAges 18–99 - NCT05554302RecruitingPhase 2
PET scan study for brain metastases after surgery
This trial studies how well a special PET scan tracer (18F-fluciclovine) shows amino-acid changes in brain metastases after they are surgically removed. It may help improve how doctors detect and understand brain metastases and guide follow-up treatment like targeted radiation (SRS).
Miami, FloridaAges 18 years+
Hear when a new Radiotracer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for radiotracer?
- Yes. Clin2 currently lists 33 recruiting radiotracer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a radiotracer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a radiotracer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.